1 result(s) for Cabozantinib
| PI Name | Protocol # | Title |
|---|---|---|
| Christopher Ryan | IRB00009553 | A Phase 3, Randomized, Controlled Study of Cabozantinib (XL184) vs Everolimus in Subjects with Metastatic Renal Cell Carcinoma that has Progressed after Prior VEGFR Tyrosine Kinase Inhibitor Therapy |
You may qualify for additional trials within our Phase 1 Program